Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Mitchell P Weikert, ASCRS 2021: Managing Expectations for Post-refractive Cataract Surgery Patients

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 16th 2021

We were delighted to catch up with Dr Mitchell P Weikert (Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA), who shared his insights on managing expectations in cataract surgery patients who have previously undergone laser-assisted in situ keratomileusis procedures, and tips on optimizing outcomes in these patients.

Questions

  1. How do you manage expectations in cataract surgery patients who have previously undergone laser-assisted in situ keratomileusis procedures? (00:12)
  2. What tips would you like to share for optimizing outcomes in these patients? (02:26)

Speaker Disclosure: Mitchell P Weikert is a consultant for Alcon Surgical, Inc. and Carl Zeiss Meditec, Inc.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of ASCRS 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup